Symbiotec Pharmalab Ltd. makes a weak debut on the bourses with scrip got listed at Rs 978.20 on the Bombay Stock Exchange, a 0.99 per cent discount to its issue price of Rs 988.00. On the National Stock Exchange, the stock was listed at Rs 988.00.
The company, which raised 1.78 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 177.83 lakhs shares.
The company, listed under B Group Securities post its IPO, opened for subscription from Aug 24 to Aug 27.
Following a weak opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE.
The company anticipates using the proceeds of the issue for .
Motilal Oswal Investment Advisors Limited,Nomura Financial Advisory & Securities (I) P Ltd.,JM Financial Limited,Avendus Capital Pvt. Ltd. as lead managers & MUFG Intime India Pvt. Ltd. is the registrar, to the issue.
Meanwhile, the broader benchmark BSE Sensex closed trade at 76,957.27, down 307.24 points, or 0.39 per cent.